Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

1.40USD
20 Sep 2016
Change (% chg)

-- (--)
Prev Close
$1.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,668
52-wk High
$5.75
52-wk Low
$0.85

PRTX.PK

Chart for PRTX.PK

About

Protalex, Inc. is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company's lead product candidate, PRTX-100, is a formulation of the Staphylococc... (more)
No analyst recommendations are available for PRTX.PK.

Overall

Beta: -0.08
Market Cap(Mil.): $40.27
Shares Outstanding(Mil.): 28.77
Dividend: --
Yield (%): --

Financials

  PRTX.PK Industry Sector
P/E (TTM): -- 36.61 36.60
EPS (TTM): -0.33 -- --
ROI: -5,697.53 14.46 13.91
ROE: -- 15.26 14.82

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.